Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adma Biologics (ADMA) Deferred Taxes (2024 - 2025)

Historic Deferred Taxes for Adma Biologics (ADMA) over the last 2 years, with Q3 2025 value amounting to $4.8 million.

  • Adma Biologics' Deferred Taxes changed N/A to $4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $94.1 million, marking a year-over-year change of. This contributed to the annual value of $84.3 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that Adma Biologics reported Deferred Taxes of $4.8 million as of Q3 2025.
  • Adma Biologics' 5-year Deferred Taxes high stood at $84.3 million for Q4 2024, and its period low was $1.6 million during Q2 2025.